urea has been researched along with Leishmaniasis, Visceral in 15 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The application of RF07 in the treatment of visceral leishmaniasis suggests that it is an alternative to the disease, since the reversal of clinical signs in dogs with VL requires the use of 0." | 1.56 | preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis? ( Braz, DC; Cunha, RLOR; das Chagas Pereira de Andrade, F; de Amorim Carvalho, FA; de Carvalho Maia, OA; Filgueiras, LA; Maia Filho, ALM; Mendes, AN; Rodezno, SVA; Viana Nunes, AM, 2020) |
| "Visceral leishmaniasis is a severe parasitic disease that is one of the most neglected tropical diseases." | 1.42 | Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity. ( Braillard, S; Brown, AD; Cao, Y; Feijens, PB; Gardner, JM; Gibson, KR; Glossop, PA; Hua, W; Maes, LJ; Matheeussen, A; Mills, JE; Morgans, GL; Mowbray, CE; Speed, W; Whitlock, GA, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (33.33) | 18.7374 |
| 1990's | 4 (26.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| de Jong, MK | 1 |
| Rappoldt, A | 1 |
| Broere, F | 1 |
| Piek, CJ | 1 |
| Viana Nunes, AM | 1 |
| das Chagas Pereira de Andrade, F | 1 |
| Filgueiras, LA | 1 |
| de Carvalho Maia, OA | 1 |
| Cunha, RLOR | 1 |
| Rodezno, SVA | 1 |
| Maia Filho, ALM | 1 |
| de Amorim Carvalho, FA | 1 |
| Braz, DC | 1 |
| Mendes, AN | 1 |
| Killick-Kendrick, R | 1 |
| Asad, M | 1 |
| Bhattacharya, P | 1 |
| Banerjee, A | 1 |
| Ali, N | 1 |
| Mowbray, CE | 1 |
| Braillard, S | 1 |
| Speed, W | 1 |
| Glossop, PA | 1 |
| Whitlock, GA | 1 |
| Gibson, KR | 1 |
| Mills, JE | 1 |
| Brown, AD | 1 |
| Gardner, JM | 1 |
| Cao, Y | 1 |
| Hua, W | 1 |
| Morgans, GL | 1 |
| Feijens, PB | 1 |
| Matheeussen, A | 1 |
| Maes, LJ | 1 |
| Pessoa-E-Silva, R | 1 |
| Mendonça Trajano-Silva, LA | 1 |
| Lopes da Silva, MA | 1 |
| da Cunha Gonçalves-de-Albuquerque, S | 1 |
| de Goes, TC | 1 |
| Silva de Morais, RC | 1 |
| Lopes de Melo, F | 1 |
| de Paiva-Cavalcanti, M | 1 |
| CHEN, TT | 1 |
| HO, EA | 1 |
| SOONG, TH | 1 |
| LI, Y | 1 |
| Medda, S | 1 |
| Mukherjee, S | 1 |
| Das, N | 2 |
| Naskar, K | 2 |
| Mahato, SB | 3 |
| Basu, MK | 2 |
| Al-Saffar, NR | 1 |
| Al-Mudhaffer, SA | 1 |
| Prasad, LS | 1 |
| Sen, S | 1 |
| Ganguly, SK | 1 |
| Ghosh, DK | 3 |
| Ghosh, AK | 2 |
| Mukerji, K | 2 |
| Pal, BC | 1 |
| Khan, S | 1 |
| Brahmachari, UN | 1 |
15 other studies available for urea and Leishmaniasis, Visceral
| Article | Year |
|---|---|
Survival time and prognostic factors in canine leishmaniosis in a non-endemic country treated with a two-phase protocol including initial allopurinol monotherapy.
Topics: Allopurinol; Animals; Creatinine; Dog Diseases; Dogs; Humans; Leishmania infantum; Leishmaniasis; Le | 2023 |
preADMET analysis and clinical aspects of dogs treated with the Organotellurium compound RF07: A possible control for canine visceral leishmaniasis?
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antiprotozoal Agents; Aspartate Aminotransferas | 2020 |
The race to discover the insect vector of kala-azar: a great saga of tropical medicine 1903-1942.
Topics: Animals; Antiprotozoal Agents; History, 20th Century; Humans; India; Insect Bites and Stings; Insect | 2013 |
Therapeutic and immunomodulatory activities of short-course treatment of murine visceral leishmaniasis with KALSOME™10, a new liposomal amphotericin B.
Topics: Amphotericin B; Animals; Antiprotozoal Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocyte | 2015 |
Novel Amino-pyrazole Ureas with Potent In Vitro and In Vivo Antileishmanial Activity.
Topics: Animals; Antiparasitic Agents; Cricetinae; Female; Humans; Leishmania donovani; Leishmania infantum; | 2015 |
Evaluation of urine for Leishmania infantum DNA detection by real-time quantitative PCR.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Brazil; Child; Creatinine; DNA, Kinetop | 2016 |
Rapid treatment of Chinese kala-azar with urea stibamine; a report of 12 cases.
Topics: Humans; Leishmaniasis; Leishmaniasis, Visceral; Organometallic Compounds; Urea | 1949 |
Rate of disappearance of Leishmania in kala-azar patients under urea stibamine therapy.
Topics: Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Organometallic Compounds; Urea | 1949 |
Sugar-coated liposomes: a novel delivery system for increased drug efficacy and reduced drug toxicity.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Drug Carriers; Drug Compounding; | 1993 |
Lactate dehydrogenase and other enzymes in kala-azar patients in Iraq.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child, Preschool; Creatine Kinase; Humans; Hydrox | 1979 |
Renal involvement in kala-azar.
Topics: Animals; Cricetinae; Female; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Leishmania | 1992 |
Targeting of urea stibamine encapsulated in liposomes to reticuloendothelial system for the treatment of experimental leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Drug Carriers; Leishmaniasis, Visceral; Liposomes; Mannos | 1990 |
Effect of ureastibamine on Leishmania donovani amastigote.
Topics: Animals; Antiprotozoal Agents; Cricetinae; Disease Models, Animal; Leishmania donovani; Leishmaniasi | 1990 |
Urea stibamine: an improved method of preparation and its antileishmanial activity.
Topics: Animals; Antimony; Antiprotozoal Agents; Cricetinae; DNA Replication; Glycolysis; Indicators and Rea | 1987 |
Chemotherapy of antimonial compounds in kala-azar infection. Part IV. Further observations on the therapeutic values of urea stibamine. By U.N. Brahmachari, 1922.
Topics: Antimony; Antiprotozoal Agents; History, 20th Century; Humans; Leishmaniasis, Visceral; Organometall | 1989 |